Anthem, Athens Orthopedic Clinic Partner to Expand Orthopedic Access in Northeast Georgia Anthem Blue Cross and Blue Shield of Georgia has entered into a strategic partnership with Athens Orthopedic Clinic…
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® GoodRx the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen® (for single-patient-use) through GoodRx Employer Direct.…
FDA Greenlights Sotyktu to Treat Active Psoriatic Arthritis in Adults The U.S. Food and Drug Administration (FDA) has approved Sotyktu (deucravacitinib), developed by Bristol Myers Squibb, for the treatment of…
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results Silence Therapeutics plc, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies,…
Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening…
Polares Medical Raises $50 Million Series C to Advance U.S. Expansion of MRace Following Strong Clinical Results Polares Medical SA a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement (PLR)…
STAAR Surgical Releases Update in New Shareholder Letter STAAR Surgical Company the global leader in phakic intraocular lenses (IOLs) and maker of the EVO family of Implantable Collamer® Lenses (EVO…
Delcath Systems Reports Publication of CHOPIN Clinical Trial Findings in The Lancet Oncology Delcath Systems, Inc. an interventional oncology company focused on the treatment of primary and metastatic liver cancers,…
EU Regulatory Reforms and Global Healthcare Innovation to Be Central Focus at DIA Europe 2026 DIA, a global non-profit association of life sciences professionals, has announced that DIA Europe 2026…
National Grange Backs New Report Warning of Rural Health Funds Being Redirected to Urban Hospitals The National Grange has expressed strong support for the release of a comprehensive new analysis…
Strategic $7.65 Million Collaboration Aims to Accelerate Development of a Novel ANO5 Gene Replacement Therapy Toward Clinical Trials Cure Rare Disease (CRD), a nonprofit biotechnology organization dedicated to developing treatments…
MySpaLive’s Compliance and Training Framework As conversations continue across the medical aesthetics industry regarding claims that Texas has “closed a med spa loophole” in 2026, MySpaLive is issuing a detailed…